Drug Shortage Report for AURO-REPAGLINIDE
Report ID | 219319 |
Drug Identification Number | 02424266 |
Brand name | AURO-REPAGLINIDE |
Common or Proper name | AURO-REPAGLINIDE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-12 |
Estimated end date | 2024-03-29 |
Actual end date | 2024-03-27 |
Shortage status | Resolved |
Updated date | 2024-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-03-28 | English | Compare |
v5 | 2024-03-27 | French | Compare |
v4 | 2024-03-27 | English | Compare |
v3 | 2024-02-13 | English | Compare |
v2 | 2024-02-12 | French | Compare |
v1 | 2024-02-12 | English | Compare |
Showing 1 to 6 of 6